Quadrant Biosciences is a collaborative effort led by company founder Richard Uhlig. Our management team has been carefully balanced to facilitate the ongoing development, testing and distribution of our products, and includes expertise in engineering, FDA regulatory compliance, production, marketing and sales. Our advisory board comprises highly regarded medical experts and data scientists.
Our Executive Team
With more than 25 years of business experience focused on the design and development of innovative products across various industries, Richard’s management capabilities range from ownership of regional retail businesses to the start-up and management of major corporate divisions with domestic and international product sourcing and sales experience. Previously, he was the Chairman and Chief Executive Officer of Morgan Stanley Bank, the principal banking subsidiary of Morgan Stanley, and was the Chief Investment Officer at Merrill Lynch Bank. He held other significant posts in the financial industry and served as an Executive in Residence at Cornell University’s Johnson Graduate School of Management. Richard is a graduate of Cornell University.
Cynthia Dowd Greene
Cynthia has a track record of success in the healthcare industry, working with start-up companies and large multinational corporations. She worked for Bristol Myers Squibb for many years, where she was a member of the executive teams of the US Oncology and Immunology Group and Technical Operations. Upon leaving Bristol Myers Squibb, Cynthia went on to help build several successful small companies. This path led her to join the Academic Medical Health Center at SUNY Upstate Medical University, where she worked with medical researchers and local start-up companies in the healthcare field. Cynthia received a BS in Chemical Engineering from Clarkson University and an MBA from the University of Connecticut.
Chrys is a well-rounded, entrepreneurial and growth-focused leader with a proven track record of success delivering results in diverse disciplines during a 20-plus-year career. Prior to joining Quadrant Biosciences, Chrys spent more than nine years with Zimmer Biomet, including roles as the Global Head of Finance for Zimmer Biomet’s Spine, Dental and CMF & Thoracic divisions, Senior Director of Finance, Operations and Logistics for Canada, and Director of Finance for Canada and Latin America. Prior to Zimmer Biomet, Chrys worked in various other senior positions, including Director of Finance at Stryker Canada and General Manager at Nadiscorp Logistics Group. Chrys holds an honors Bachelor of Business Administration from Wilfrid Laurier University in Waterloo, Ontario, Canada, and is a Chartered Professional Accountant.
David has more than 25 years of business, research and legal experience. He recently produced two award-winning feature and documentary films and founded an MMA website and clothing company. David was a co-owner of a mixed-martial arts promotion company and co-owner and manager of a medical-device sales distribution company. Previously, he was a litigator at the firms of LeBoeuf, Lamb, Lieby & MacRae and Nixon Hargrave Devans & Doyle. Earlier, he was a research biologist for the Cornell University Lab of Ornithology. David earned a BS from Cornell University and a JD from the University at Buffalo Law School, where he was a member of the Law Review.
Randall L. Carpenter, MD
Dr. Carpenter has more than 30 years of experience in primary care, academic medicine, basic science and clinical research, and pharmaceutical drug development. His experience in the pharmaceutical and biotechnology industries includes Co-Founder, President and CEO of Seaside Therapeutics, President and CEO of Sention, VP of Clinical Research & Development and Regulatory Affairs at Adolor Corporation, and member of Astra Pain Control’s Global Therapeutic Area Team. While in industry, Dr. Carpenter led translational medicine teams responsible for eight successful IND submissions and dozens of GCP-compliant clinical trials. Prior to joining industry, he held academic faculty appointments at Virginia Mason Medical Center, the University of Washington and Wake Forest University, where he specialized in anesthesiology, pain management and translational medicine.
Scott has over 25 years experience in the medical device and health industry working with both multi-national corporations and startup companies. For the last ten years, he has managed Scott Alan Enterprises, a boutique firm building management organizations, creating driven sales teams, and implementing strategic positioning and marketing campaigns to fill needed skill sets for medical device and health IT companies. Previously, Scott honed his leadership skills and industry knowledge for fourteen years at Stryker Corporation and later at OraMetrix. Scott earned an MBA in Entrepreneurship & Marketing from Carnegie Mellon University and bachelor's degrees in Economics and Chemistry from Cornell University.
Jim was previously a structured finance/banking partner at Chapman & Cutler, Orrick, Herrington, Cadwalader and Hunton & Williams. Throughout his career, he served as counsel to underwriters and issuers in U.S. and global public offerings and private placements. Jim has been a member of the board of directors of the American Securitization Forum and a faculty member of the Practicing Law Institute. He has written and lectured on a variety of topics regarding legal and regulatory issues and annually served as a guest lecturer regarding U.S. corporate and finance law at The Universidad Panamericana in Guadalajara, Mexico. Jim practiced U.S. law in London from 1999 - 2004, as the head of Cadwalader, Wickersham & Taft LLP's London capital markets department. Jim earned his undergraduate degree in Mathematics from the University of Kentucky and his J.D. degree from the University of Notre Dame Law School.
Chris has more than 20 years of experience as corporate counsel on matters including transactions, business development, intellectual property, and regulatory compliance. He served as Deputy General Counsel and Compliance Officer for Welch Allyn, Inc. for more than 10 years, and in that capacity managed the attorneys in the legal department who worked in the areas of transactions, intellectual property, and compliance, and also served on the executive team that managed the Quality and Regulatory departments. Chris is an adjunct professor at the Syracuse College Of Law, and teaches a section of the class on technology commercialization. He received a BS in Medicine from the University of Nebraska, and a JD, with distinction, from the University of Nebraska College Of Law.
Alexander Rajan, PhD
Dr. Rajan has a varied career in biomedical sciences, from basic and translational research, life science and computational biology education and outreach, emergency medicine, and biotech startups. He began his research career investigating autism diagnostics, and has managed, led, and consulted on research projects in vision, somatosensation, proprioception, and motor systems involving biomechanics, neuroanatomy, electrophysiology, and stimulation. His funding sources have included the NSF, NIH, and DARPA. His startup work has been in sales and marketing and in research and development. Dr. Rajan earned a BS in biopsychology from the University of California, Davis and a PhD in computational neuroscience from the University of Chicago.
Andrew brings a strong background in hardware design and development to the Motion Intelligence team. His career has included more than 12 years in the defense industry, working on sophisticated radar systems such as the DARPA FORESTER, the Army’s AN/TPQ-49 and radar antennas for drone helicopters. Andrew developed and holds patents on new technologies involving efficient heat transfer and has a strong background in algorithm development, having created algorithms for deep-sea underwater sensors and sports performance technologies. More recently, he has run his own engineering consulting business with a focus on commercial manufacturing and medical devices. Andrew received a BS in Mechanical Engineering with a minor in Mathematics from Clarkson University.
Ben’s career in technology encompasses a wide breadth of expertise in software development, including enterprise web applications, cloud computing and human/computer interaction. During his experience as both a senior developer and project manager, he led projects involving crowdsourced metadata curation, inventory control tools and identity management solutions. Before coming to Motion Intelligence, Ben developed software for the federal statistical system and public opinion domain. He received his master’s degree in Information Science from Cornell University.
Jeremy has developed software solutions in the financial sector, the GIS industry and in support of large-scale social science research. He has held leadership roles in a number of successful projects, both academically and commercially. He was responsible for designing a citizen science project funded by the NEH and used in secondary schools and colleges across the country. He has also led the development of restricted access Census Bureau metadata repository software funded by the NSF. His experience spans complex systems integration, mapping software used by state and municipal governments to manage geo-spatial data, and applications for research data analysis and dissemination. During Jeremy’s career, he has developed expertise in a variety of technologies, with a focus on information system architecture. He graduated with a Master’s degree in Information Science from Cornell University.
Bryan brings to the Motion Intelligence team more than 10 years of experience in medical device operations, manufacturing, validation and new-product introduction at both large multinational and start-up corporations. He has a proven track record of successfully introducing Class I, II and III products at Life Technologies (Thermo Fisher Scientific), Pall Corporation and ImClone System (Eli Lilly). Most recently, Bryan was the manufacturing and operations leader during establishment and implementation of an FDA 21CFR820 compliant system at Rheonix, a medical device start-up. He received a BS in Chemical Engineering from Clarkson University.
Dave’s career has spanned the spectrum of software development including enterprise, web, and mobile applications. While a senior developer, he led projects involving cloud computing, scalability, and internationalization. Prior to joining Quadrant Biosciences, Dave built iOS and Android applications supporting citizen science projects used by over 100,000 people globally in over 20 languages. He received a Bachelor’s degree in Computer Science from the Rochester Institute of Technology.
Medical and Scientific Collaborators
Anthony Petraglia, MD
Dr. Petraglia is an attending Neurosurgeon at Rochester Regional Health in Rochester, NY, and specializes in all aspects of spine and brain surgery. He has extensive subspecialty experience in sports-related neurological injuries, co-authoring with Dr. Julian Bailes the Handbook of Neurological Sports Injuries, a well-regarded treatise on concussion in sports. Dr. Petraglia is the Executive Director of the Rochester Regional Concussion Center.
Steven Hicks, MD, PhD
Dr. Hicks is an Assistant Professor of Academic General Pediatrics at Pennsylvania State College of Medicine in Hershey, PA. He is a physician scientist who studies the influence of genetics and the environment on pediatric diseases involving growth and neurodevelopment. More specifically, Dr. Hicks is interested in how peripheral epigenetic factors such as microRNA may be utilized to predict patient oriented outcomes in pediatric disorders of neurodevelopment (e.g. autism, concussion) and growth (e.g. annorexia nervosa, obesity). His research has been recently published in JAMA Pediatrics and the Journal of Neurotrauma.
Frank Middleton, PhD
Dr. Middleton is an Associate Professor in the Department of Neuroscience & Physiology, Department of Psychiatry & Behavioral Sciences and the Department of Biochemistry & Molecular Biology at SUNY Upstate Medical University. He is the founder and director of the SUNY Molecular Analysis Core facility, which specializes in next-generation sequencing analysis, and has published more than 120 peer-reviewed articles and a dozen book chapters. He is a chief section editor for Behavioral Brain Functions and Frontiers in Genetics.
Christopher Neville, PhD
Dr. Neville is an associate Professor of Clinical Health Practices at SUNY Upstate Medical University, and has a clinical background as a physical therapist, treating patients with mild traumatic brain injury and various orthopedic conditions before completing his PhD in Health Practice Research with a Biometrics focus. He has more than 50 peer-reviewed journal and conference publications, as well as a history of federal grant funding.
Brian Rieger, PhD
Dr. Rieger is the director of the Concussion Center at SUNY Upstate Medical University and a Clinical Assistant Professor of Rehabilitation Psychology, Dr. Rieger specializes in concussion management and sports-related concussion.
Claudine Ward, MD
Dr. Ward is an assistant Professor of Physical Medicine and Rehabilitation at SUNY Upstate Medical University, Dr. Ward is a clinician who specializes in acquired brain injury, including concussion and management of spasticity.
Data Management Collaborators
William C. Block, PhD
Dr. Block is the director of the Cornell Institute for Social and Economic Research (CISER)—home of the world’s most advanced environments for research with restricted social, economic and health data—Dr. Block has Special Sworn Status for working with restricted federal statistical data. Prior to Cornell, he spent nearly 20 years at the Minnesota Population Center.